ABSTRACT
Background There is a need for follow-up of early-life stunting intervention trials into childhood to determine their long-term impact. A holistic school-age assessment of health, growth, physical and cognitive function will help to comprehensively characterise the sustained effects of early-life interventions.
Methods The Sanitation Hygiene Infant Nutrition Efficacy (SHINE) trial in rural Zimbabwe assessed the effects of improved infant and young child feeding (IYCF) and/or improved water, sanitation and hygiene (WASH) on stunting and anaemia at 18 months. Among children enrolled to SHINE, 1300 are undergoing follow-up at 7-8 years of age (1000 HIV-unexposed and 300 HIV-exposed children). Children are assessed using the School-Age Health, Activity, Resilience, Anthropometry and Neurocognitive (SAHARAN) toolbox, which provides a holistic measurement of growth, body composition, cognitive and physical function. In parallel, a detailed caregiver questionnaire assesses household demographics, socioeconomic status, adversity, nurturing, caregiver support, food and water insecurity. A monthly morbidity questionnaire is administered by community health workers to evaluate school-age rates of infection and healthcare-seeking. The impact of the SHINE IYCF and WASH interventions, the early-life ‘exposome’, maternal HIV, and contemporary exposures on each school-age outcome will be assessed. We will also undertake an exploratory factor analysis to generate new, simpler metrics for assessment of cognition (COG-SAHARAN), growth (GROW-SAHARAN) and combined growth, cognitive and physical function (SUB-SAHARAN). The SUB-SAHARAN toolbox will be used to conduct annual assessments within the SHINE cohort from ages 8-12 years.
Ethics and dissemination The study has been approved by the Medical Research Council of Zimbabwe (dated 8th February 2021) and registered with Pan-African Clinical Trials Registry (PACTR202201828512110). Primary caregivers provide written informed consent and children written assent. Findings will be disseminated to the community at sensitisation events, through conference presentations, peer-reviewed journals and key stakeholders including the Zimbabwean Ministry of Health and Child Care, and UNICEF.
Article Summary
This protocol describes the follow-up of school-age children after receiving early-life IYCF and WASH interventions in rural Zimbabwe.
A comprehensive measurement of the child’s health, growth, body composition, physical and cognitive function will be performed.
Analysis of the ‘exposome’, including maternal HIV status, will identify the early-life factors that shape school-age physical and cognitive function
Capitalizing on the randomized trial design will allow the long-term effects of IYCF and WASH on child health outcomes to be estimated.
Limitations include the re-enrolment of only a subgroup of children from one of the two original study districts; exclusion of HIV-positive children; and the long period between early-life randomized interventions and school-age outcome assessment.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
Funding Statement
Funded by Wellcome (grants 220671/Z/20/Z and 108065/Z/15/Z), National Institutes of Health (grant R61HD103101), Thrasher Research Fund (grant 15250) and Innovative Methods and Metrics for Agriculture and Nutrition Actions (IMMANA; grant 3.02).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study has been approved by the Medical Research Council of Zimbabwe (dated 8th February 2021) and registered with Pan-African Clinical Trials Registry (PACTR202201828512110).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Additional author Virginia Sauramba and Mary Muchekera have been added. The 'SHINE Follow-up collaborative author team' has been deleted as an author. Additional wording to explain snacks being offered and also clarifying the definition of the primary caregiver (particularly when not the mother).
Data Availability
All data produced in the present study are available upon reasonable request to the authors
